These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6290849)

  • 21. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay.
    Tuaillon E; Tabaa YA; Petitjean G; Huguet MF; Pajeaux G; Fondere JM; Ponseille B; Ducos J; Blanc P; Vendrell JP
    J Immunol Methods; 2006 Aug; 315(1-2):144-52. PubMed ID: 16959261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfer of antigen-presenting capacity to Ia-negative cells upon fusion with Ia-bearing liposomes.
    Coeshott C; Grey HM
    J Immunol; 1985 Mar; 134(3):1343-8. PubMed ID: 2981915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of candidate combination vaccine for hepatitis E and hepatitis B: a liposome encapsulation approach.
    Shrivastava S; Lole KS; Tripathy AS; Shaligram US; Arankalle VA
    Vaccine; 2009 Nov; 27(47):6582-8. PubMed ID: 19747579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the study of Sendai virus hemolysis. I. Complete Sendai virus lacking in hemolytic activity.
    Homma M; Shimizu K; Shimizu YK; Ishida N
    Virology; 1976 May; 71(1):41-7. PubMed ID: 58472
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B.
    Maheshwari C; Pandey RS; Chaurasiya A; Kumar A; Selvam DT; Prasad GB; Dixit VK
    Int Immunopharmacol; 2011 Oct; 11(10):1516-22. PubMed ID: 21609785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization.
    Gupta PN; Vyas SP
    Colloids Surf B Biointerfaces; 2011 Jan; 82(1):118-25. PubMed ID: 20843665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elastic liposomes mediated transcutaneous immunization against Hepatitis B.
    Mishra D; Dubey V; Asthana A; Saraf DK; Jain NK
    Vaccine; 2006 May; 24(22):4847-55. PubMed ID: 16600441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Establishment of hepatitis B virus model animals by HVJ-liposome method].
    Kato K
    Nihon Rinsho; 1993 Feb; 51(2):525-30. PubMed ID: 8385244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of human antibodies to hepatitis B surface antigen (HBsAg) by an enzyme-immunoassay for HBsAg.
    Wolters G; Kuijpers L; Schuurs A
    J Clin Pathol; 1979 Dec; 32(12):1264-71. PubMed ID: 395171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins.
    Finberg R; Mescher M; Burakoff SJ
    J Exp Med; 1978 Dec; 148(6):1620-7. PubMed ID: 214512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the ganglioside GD1a as a receptor for Sendai virus.
    Epand RM; Nir S; Parolin M; Flanagan TD
    Biochemistry; 1995 Jan; 34(3):1084-9. PubMed ID: 7827024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of Sendai virus-induced chromosome pulverization to cell cyclus in HeLa cells.
    Stenman S; Saksela E
    Hereditas; 1971; 69(1):1-14. PubMed ID: 4376137
    [No Abstract]   [Full Text] [Related]  

  • 37. Reconstitution and fusogenic properties of Sendai virus envelopes.
    Harmsen MC; Wilschut J; Scherphof G; Hulstaert C; Hoekstra D
    Eur J Biochem; 1985 Jun; 149(3):591-9. PubMed ID: 2408889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of a screening system for selection of siRNA target sites directed against hepatitis B virus surface gene.
    Zhou XM; Lin JS; Shi Y; Tian DA; Huang HJ; Zhou HJ; Jin YX
    Acta Biochim Biophys Sin (Shanghai); 2005 May; 37(5):310-6. PubMed ID: 15880259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
    Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
    Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A human-derived protein SBP (HBsAg-binding protein) can bind to hepatitis B virus surface antigen (HBsAg) and enhance the immune response to hepatitis B virus (HBV) vaccine.
    Zhang C; Gong L; Chen Y; Wang X; Zhu S; Li D; Pang Y; Yin Y; Liu X; Zhu N
    Mol Immunol; 2013 Jan; 53(1-2):60-71. PubMed ID: 22809814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.